Quest Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-20,673
Closed -$1.59M 106
2018
Q4
$1.59M Sell
20,673
-357
-2% -$27.8K 0.25% 68
2018
Q3
$1.62M Buy
21,030
+436
+2% +$32.2K 0.23% 71
2018
Q2
$1.39M Buy
20,594
+2,624
+15% +$181K 0.21% 76
2018
Q1
$1.3M Buy
+17,970
New +$1.37M 0.2% 79
2016
Q4
Sell
-79,710
Closed -$5.64M 107
2016
Q3
$5.64M Sell
79,710
-108,850
-58% -$7.93M 0.74% 55
2016
Q2
$13.9M Sell
188,560
-46,667
-20% -$3.22M 1.9% 19
2016
Q1
$15.3M Buy
235,227
+39,283
+20% +$2.67M 2.1% 4
2015
Q4
$15.1M Buy
195,944
+40,535
+26% +$3.22M 2.05% 5
2015
Q3
$12.8M Buy
155,409
+22,828
+17% +$2.03M 1.79% 12
2015
Q2
$11.7M Buy
+132,581
New +$12.2M 1.64% 10

Other funds holding NVS

Quest Investment Management's NVS Position: Q1 2019 in Review

Quest Investment Management sold out of Novartis (NVS) in Q1 2019, closing a stake of 20,673 shares — an estimated $1.59M sold.

Quest Investment Management first reported a position in NVS in Q2 2015 and held it in 10 quarters. The position peaked at $15.3M in Q1 2016. 1,133 funds tracked by Wall St. Rank hold NVS as of Q1 2019.

  • Quest Investment Management reported no remaining Novartis position as of Q1 2019 after selling out during the quarter.
  • Quest Investment Management sold 20,673 Novartis shares in Q1 2019, an estimated $1.59M.
  • Quest Investment Management first reported a position in Novartis in Q2 2015 and held it in 10 quarters.
  • Quest Investment Management's Novartis position peaked at $15.3M in Q1 2016.
  • 1,133 funds tracked by Wall St. Rank held Novartis as of Q1 2019.

Based on Quest Investment Management's 13F filing for Q1 2019, filed 14 May 2019.